Cancer Immunotherapy Treatment for NSCLC, ES-SCLC, HCC, Advanced Melan

- tecentriq.com

Learn about TECENTRIQ® (atezolizumab), a cancer Immunotherapy treatment for Non-Small Cell Lung Cancer after surgery and chemo, Metastatic Non-Small Cell Lung Cancer (NSCLC), Extensive-Stage Small Cell Lung Cancer (ES-SCLC), Liver cancer (HCC), Advanced Melanoma & Advanced Bladder Cancer (mUC) | TECENTRIQ® (atezolizuma

1,328,153 $ 1,200.00